Attendee search 

Onbone Oy (“Onbone” or the “Company”), is a Finnish life science company founded in 2008 and based in Helsinki, Finland. Company launched it´s first product, WOODCAST® Splint intended for upper limb immobilization, in mid-2010 to Finnish markets. Since then WOODCAST® has grown into comprehensive range of casting products which are available in 11 countries across Europe with over 40 000 units shipped to date. Onbone is owned by its founders and Inveni Capital, a Finnish-German life science venture fund.

WOODCAST® products are based on significant proprietary technology and are protected by a robust patent portfolio. The Company has filed five patents covering the wood composite material, its application in orthopedics and its production.

Currently orthopedic casting is made with either plaster or glass fiber type synthetic casting products which both represent technology dating back several decades. The main problems associated with plaster and glass fiber products are messy time consuming application procedure and occupational safety risk for users posed by toxic components. However, due to lack of alternative products they are still used all over the world today.

The Company’s WOODCAST® product line represents a breakthrough technology and is the first significant cast innovation in decades with potential to gain substantial share in the highly profitable fracture treatment and orthopedic support market. WOODCAST® products are easy-to-use, non-toxic and biodegradable and have received enthusiastic responses from health care professionals all over.

For hospitals Woodcast offers increased safety and cost efficiency of the cast room operation. Additionally increasing number of hospitals have adopted environmentally sustainable product management strategies which favor the use of ecological/biodegradable alternatives when available, making Woodcast the only option.

During three first years on the market in Finland, Woodcast has been installed to 80 % of hospitals and sales have grown in three digit rate annually. Since launch in Germany in early 2013, Woodcast has been installed to dozens of hospitals and over 100 hospitals are on a waiting list to have a product trial.

The global addressable market for Woodcast products is € 1,5 billion from which 2/3 is in EU and US. Market is dominated by 3 global players; BSN Medical, 3M and Lohmann&Rauscher. Typical life cycle of a medical device start-up is to be acquired by a global player after commercial proof has been established.

Onbone is now seeking funding to finance expansion of distribution network in key markets; EU and US.

Innokas Medical provides services on product development, manufacturing and life-cycle management for world class medical devices. We are focused on medical devices and have tailored our processes to meet the needed quality and regulatory requirements.

Finnfund - Finnish Fund for Industrial Cooperation Ltd. - provides long-term risk capital for private projects in developing countries and Russia. Investment criteria include profitability, social and environmental responsibility and positive development impacts. Apart from co-investing with Finnish companies Finnfund can finance ventures that use Finnish technology, cooperate with Finnish partners on a long-term basis, or generate major environmental or social benefits. Since 1980 Finnfund has made nearly 300 investments in more than 50 countries. Today we have approximately 450 million euros invested in or committed to 143 projects in 27 countries.

Sensire Oy is a Finnish technology company specialized in wireless measuring and sensoring, logistics tracking and analytics with secure and scalable Cloud-service.

Sensire TempNet® Pharma-product is usable in medical industry with environmental monitoring and logistics tracking with wireless sensors used in cargo boxes, reception/delivery terminals and vehicles, in hospitals or pharmaceutical factories.

Solution ensure medicine safety from production or warehouse to distribution in hospital or other eq. medical facilities. Additional sensors can measure environmental variables, like temperature & harmful particles. One feature is to monitor bio samples taken from patients and securing item transportation and conditions from doctor’s reception to laboratory room.

Sensire's Pharma-solution offers technological excellence and own IPR, proven concept of service, security and archive, expandability with connectivity and global user access expansion possibility.